Market Tracker

10/20 6:02pm ET

Vical Inc (NASDAQ:VICL)

1.19
Data as of Oct 20
 -0.03 / -2.46%
Today’s Change
1.01
Today|||52-Week Range
1.79
+0.85%
Year-to-Date

Today’s Trading

Previous close1.22
Today’s open1.21
Day’s range1.15 - 1.22
Volume684,998
Average volume (3 months)613,743
Market cap$108.1M
Dividend yield--
Data as of 3:59pm ET, 10/20/2014

Growth & Valuation

Earnings growth (last year)-33.33%
Earnings growth (this year)+54.38%
Earnings growth (next 5 years)--
Revenue growth (last year)-55.94%
P/E ratioNM
Price/Sales13.28
Price/Book1.72

Competitors

 Today’s
change
Today’s
% change
CNATConatus Pharmaceutic...+0.24+3.51%
VTAEVitae Pharmaceutical...+1.31+20.79%
--United Gene High-Tec...+0.00+1.18%
INNLInnocoll AG-0.01-0.19%
Data as of 3:59pm ET, 10/20/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$7.7M
Annual profit (last year)-$31.2M
Net profit margin-404.74%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vijay B. Samant
Vice President-
Vaccine Research
Larry Russell Smith
Corporate headquarters
San Diego, California

Forecasts